Zobrazeno 1 - 10
of 47
pro vyhledávání: ''
Autor:
Linda de Munck, Thiemo J. A. van Nijnatten, Kristien Keymeulen, Marc B. I. Lobbes, J. M. Simons, Loes F. S. Kooreman, Sabine Siesling, Marjolein L. Smidt, Sanaz Samiei
Publikováno v:
Annals of Surgery, 271(3), 574-580. LIPPINCOTT WILLIAMS & WILKINS
Annals of Surgery, 271(3), 574-580. Lippincott Williams & Wilkins
Annals of Surgery, 271, 574-580. Lippincott Williams & Wilkins
Annals of Surgery, 271(3), 574-580. Lippincott Williams & Wilkins
Annals of Surgery, 271, 574-580. Lippincott Williams & Wilkins
Objective: The aim was to investigate whether pathologic complete response (pCR) in the breast is correlated with absence of axillary lymph node metastases at final pathology (ypN0) in patients treated with neoadjuvant systemic therapy (NST) for diff
Publikováno v:
Transplantation Direct
Transplantation Direct, Vol 7, Iss 5, p e694 (2021)
Transplantation Direct, Vol 7, Iss 5, p e694 (2021)
Posttransplant lymphoproliferative disorder (PTLD) in liver transplant recipients is relatively uncommon, with an estimated incidence of 1%–3%. Retrospective reviews of liver transplant recipients have mainly reported posttransplant lymphoprolifera
Autor:
Antonio Daniele Pinna, Natalie Filmann, Lionel Rostaing, Jens Brockmann, Michael Heise, Andreas A. Schnitzbauer, Simone I. Strasser, Giorgio Rossi, Silvio Nadalin, Jean Gugenheim, Tom M. Ganten, Umberto Cillo, Norman M. Kneteman, Koert P. de Jong, André Roy, Víctor Sánchez Turrión, Thomas Becker, Christoph Duvoux, Markus Rentsch, Jürgen Klempnauer, Utz Settmacher, George Philippe Pageaux, Christian Klein, Roberto Troisi, Edward K. Geissler, Darius F. Mirza, Gunnar Söderdahl, Peter Neuhaus, Jan Lerut, Hans J. Schlitt, Patrizia Burra, Vincenzo Mazzaferro, Johann Pratschke, T. Scholz, Neville V. Jamieson, Wolf O. Bechstein, James Powel, Thomas Soliman, Heikki Mäkisalo, Magnus Rizell, René Adam, Bart van Hoek, Michele Colledan, Itxarone Bilbao, Philippe Bachellier, Olivier Chazoullières, Sherrie Bhoori, Jaques Pirenne
Publikováno v:
Annals of Surgery, Vol. 272, no. 5, p. 855-862 (2020)
Annals of Surgery
Annals of Surgery, Lippincott, Williams & Wilkins, 2020, 272 (5), pp.855-862. ⟨10.1097/SLA.0000000000004280⟩
Annals of Surgery, 272(5), 855-862. LIPPINCOTT WILLIAMS & WILKINS
Annals of Surgery, 2020, 272 (5), pp.855-862. ⟨10.1097/SLA.0000000000004280⟩
Annals of Surgery
Annals of Surgery, Lippincott, Williams & Wilkins, 2020, 272 (5), pp.855-862. ⟨10.1097/SLA.0000000000004280⟩
Annals of Surgery, 272(5), 855-862. LIPPINCOTT WILLIAMS & WILKINS
Annals of Surgery, 2020, 272 (5), pp.855-862. ⟨10.1097/SLA.0000000000004280⟩
OBJECTIVE: The aim of this study was to evaluate the survival benefit of sirolimus in patients undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC) (exploratory analysis of the SiLVER-trial). SUMMARY AND BACKGROUND DATA: Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1366a5a25685c35d3e6bad9d9a449956
https://hdl.handle.net/2078.1/235479
https://hdl.handle.net/2078.1/235479
Autor:
Zoltan Szucs, Aisha Miah, Robin L. Jones, Helen Hatcher, Ian Judson, Charlotte Benson, Winette T. A. van der Graaf, Han Hsi Wong, Shane Zaidi, Christina Messiou
Publikováno v:
Anti-Cancer Drugs
Anti-Cancer Drugs, 28, 421-426
Anti-Cancer Drugs, 28, 4, pp. 421-426
Anti-Cancer Drugs, 28, 421-426
Anti-Cancer Drugs, 28, 4, pp. 421-426
Contains fulltext : 170336.pdf (Publisher’s version ) (Open Access) Desmoid tumour/aggressive fibromatosis (DT/AF) is a rare soft-tissue neoplasm that is locally aggressive but does not metastasize. There is no standard systemic treatment for sympt
Autor:
Hyungwoo Cho, Kyu-Pyo Kim, Hong Seok Jang, Jeong Eun Kim, Jong Hoon Kim, Myung Ah Lee, Tae-Won Kim, Dae Yong Kim, Yong Sang Hong, Jin Cheon Kim, Jae Hwan Oh, Sun-Young Kim, Seong Taek Oh, Chang Sik Yu
Publikováno v:
American Journal of Clinical Oncology
Supplemental Digital Content is available in the text.
Objectives: Controversy surrounds the management of patients with locally advanced rectal cancer with synchronous resectable liver metastases (LMs). This study was designed to improve both s
Objectives: Controversy surrounds the management of patients with locally advanced rectal cancer with synchronous resectable liver metastases (LMs). This study was designed to improve both s
Publikováno v:
Anti-Cancer Drugs
To observe drug-induced hepatotoxicity by long-term gefitinib administration in the treatment of non-small-cell lung cancer. The data of 101 patients with locally advanced or metastatic non-small-cell lung cancer, for which gefitinib had been used or
Autor:
Linda de Munck, Jacques C. de Graaf, Frank G A Jansman, Sabine Siesling, James E. Boers, Johan M. van Rooijen, Guusje M. Teeuwen
Publikováno v:
Anti-cancer drugs, 27(2), 127-132. Lippincott Williams and Wilkins
Anti-Cancer Drugs, 27(2), 127-32. LIPPINCOTT WILLIAMS & WILKINS
Anti-Cancer Drugs, 27(2), 127-32. LIPPINCOTT WILLIAMS & WILKINS
The addition of trastuzumab to chemotherapy in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) prolongs overall survival (OS) in clinical trials. However, treatment patterns and survival in daily practice are u
Autor:
David R. Thomas, Eva Havrdova, Douglas L. Arnold, Miroslav Stojanovic, Jeffrey A. Cohen, Michael Panzara, Stephen Lake, Alasdair Coles, D Alastair S Compston, Howard L. Weiner, Krzysztof Selmaj, Hans-Peter Hartung, Gavin Giovannoni, Elizabeth Fisher, David Margolin, Vesna V. Brinar
Publikováno v:
Neurology
Neurology, 87(14), 1464-1472. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 87(14), 1464-1472. LIPPINCOTT WILLIAMS & WILKINS
Objective: To describe detailed MRI results from 2 head-to-head phase III trials, Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis Study I (CARE-MS I; NCT00530348) and Study II (CARE-MS II; NCT00548405), of alemtuzumab vs subcutaneo
Autor:
Huldrych F. Günthard, Manuel Battegay, Enos Bernasconi, Stefan Erb, Alexandra Calmy, Pietro Vernazza, L Elzi, Hansjakob Furrer, Matthias Cavassini
Publikováno v:
Elzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Vernazza, Pietro; Günthard, Huldrych; Bernasconi, Enos; Battegay, Manuel (2017). Adverse events of raltegravir and dolutegravir. AIDS, 31(13), pp. 1853-1858. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001590
AIDS, vol. 31, no. 13, pp. 1853-1858
AIDS (London, England)
AIDS, Vol. 31, No 13 (2017) pp. 1853-1858
AIDS, vol. 31, no. 13, pp. 1853-1858
AIDS (London, England)
AIDS, Vol. 31, No 13 (2017) pp. 1853-1858
OBJECTIVE To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. DESIGN Prospective cohort study. METHODS All antiretroviral therapy (ART)-naive and ART-experienced HIV-infected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c07bb325d96b7974f6c2d69cf92e7e
https://boris.unibe.ch/104861/1/00002030-201708240-00010.pdf
https://boris.unibe.ch/104861/1/00002030-201708240-00010.pdf
Autor:
Hans-Peter Hartung, Sarah Griffiths, Helmut Butzkueven, Till Sprenger, Yvonne Naegelin, Rebecca Gottschalk, Ludwig Kappos, Heinz Wiendl, Gavin Giovannoni, Xavier Montalban, Nicole Mueller-Lenke, Ernst Wilhelm Radue, Giancarlo Comi, Davorka Tomic, Tobias Derfuss, Frank Dahlke, Philipp von Rosenstiel, Ying Zhang
Publikováno v:
Neurology
Objective: To investigate the effect of different natalizumab washout (WO) periods on recurrence of MRI and clinical disease activity in patients switching from natalizumab to fingolimod. Methods: In this multicenter, double-blind, placebo-controlled